logo
Deadly Massachusetts fire highlights the minimal regulations that govern assisted-living facilities

Deadly Massachusetts fire highlights the minimal regulations that govern assisted-living facilities

The Massachusetts assisted-living facility where a fatal fire killed nine people was caring for dozens of aging residents reliant on wheelchairs and oxygen tanks, but it lacked the safety measures and most of the staffing requirements that are commonplace in nursing homes.
As an assisted-living center, Gabriel House in Fall River, about 50 miles (80 kilometers) south of Boston, offered a type of housing for older residents that has expanded nationally in recent decades. But advocates argue that the absence of any federal regulations and spotty state rules mean the sector is largely left to police itself.
'The real issue is that assisted livings operate in an environment like the Wild West,' said Richard Mollot, executive director of the Long Term Care Community Coalition, a nonprofit that advocates for improved care in nursing and assisted-living facilities. 'They can pretty much do what they want with impunity, and that results in a lot of, I would say, mini-catastrophes every day, frankly.'
The fire that tore through the three-story structure late Sunday raised a host of questions about conditions at the dilapidated facility and put the spotlight on the growing number of assisted-living centers in the state and nationwide.
Created in the 1980s, assisted living has been marketed as an option for older adults who need some assistance but not as much help as a nursing home. Advocates argue that regulations for the facilities have not kept up as more locations have opened.
Nursing homes, for example, are governed by federal regulations because they receive Medicare and Medicaid while there are no federal regulations for assisted-living facilities. Nursing homes must have a minimum number of staffers and trained medical professionals such as doctors and nurses, but assisted-living facilities have no such requirements.
'The regulations are minimal,' said Liane Zeitz, an attorney who is also a member of the state Assisted Living Residences Commission, a body created to make recommendations about the sector. She has advocated for more regulations for assisted-living facilities.
The facilities were lightly regulated because initially they were regarded as residential, with lower levels of care and less oversight, she said. But now those facilities are caring for a population 'that is much frailer, and the population is growing.'
Not only are the regulations weaker for assisted-living facilities, but advocates argue that the enforcement of the existing rules is often lax.
Paul Lanzikos, a former Massachusetts secretary of elder affairs and co-founder of the advocacy group Dignity Alliance, described a 'patchwork' of regulations across the country, with different agencies involved depending on the state.
'Some of the states are much more regulated. Some are regulated as a health care entity. Others, as we do here in Massachusetts, are considered a residential housing model,' he said.
U.S. Sen. Elizabeth Warren, a Massachusetts Democrat, has been advocating for increased oversight for years, particularly after the release of reports about health and safety problems in 2018.
'These are serious problems that have been going on for years,' she said at a hearing last year. 'But we hear so much less about what's going in assisted-living facilities than we do in other facilities, like nursing homes.'
At that hearing, Mollot noted that scandals in the nursing home industry pushed Congress to act in the 1970s and 1980s, and that such a reckoning could be coming soon for assisted living. He described two major risks: increasingly sick and vulnerable assisted living residents and financial exploitation by owner investors.
Speaking Wednesday after learning about the Gabriel House fire, Mollot said the problems that plagued that facility are not unique to Massachusetts.
'Unlike nursing homes, assisted living has no federal state requirements, no requirement for staffing, no requirements for staff training, no requirements for safety protocols, no requirements for inspections,' he said. 'That falls to the states, and the states have overall very weak rules.'
___
Associated Press writers Holly Ramer and Matt O'Brien contributed to this report.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Planned Parenthood wins partial victory in legal fight with Trump administration over funding cuts
Planned Parenthood wins partial victory in legal fight with Trump administration over funding cuts

Winnipeg Free Press

timea day ago

  • Winnipeg Free Press

Planned Parenthood wins partial victory in legal fight with Trump administration over funding cuts

BOSTON (AP) — Planned Parenthood won a partial victory Monday in a legal fight with President Donald Trump's administration over efforts to defund the organization in his signature tax legislation. A provision in that bill would end Medicaid payments to abortion providers for one year. But U.S. District Judge Indira Talwani in Boston granted a preliminary injunction Monday that, for now, blocks the government from cutting Medicaid payments to Planned Parenthood member organizations that either don't provide abortion care or didn't meet a threshold of at least $800,000 in Medicaid reimbursements in a given year. It wasn't immediately clear how many Planned Parenthood organizations and clinics would continue to get Medicaid reimbursement under that decision and how many might not. Wednesdays Columnist Jen Zoratti looks at what's next in arts, life and pop culture. The lawsuit was filed earlier this month against Health and Human Services Secretary Robert F. Kennedy Jr. by Planned Parenthood Federation of America and its member organizations in Massachusetts and Utah. A Planned Parenthood spokesperson said its lawyers were still examining the order and would release a statement shortly.

FDA names former pharmaceutical company executive to oversee US drug program
FDA names former pharmaceutical company executive to oversee US drug program

Winnipeg Free Press

timea day ago

  • Winnipeg Free Press

FDA names former pharmaceutical company executive to oversee US drug program

WASHINGTON (AP) — The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the latest in a string of leadership changes at the agency. FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency's Center for Drug Evaluation and Research, which regulates the safety and effectiveness of all U.S. drugs. His appointment comes a month after the center's acting director, Dr. Jacqueline Corrigan-Curay, announced her retirement. As the agency's top drug regulator, Tidmarsh will be charged with following through on a number of commitments made by Makary and his boss, Health Secretary Robert F. Kennedy Jr., including reviewing the safety of the abortion pill mifepristone. The FDA is also scrutinizing certain uses of other long-established drugs, including antidepressants and hormone-replacement drugs for menopause. Tidmarsh founded and led several pharmaceutical companies, including Horizon Pharmaceuticals, maker of an anti-inflammatory medication for arthritis. He has also served as an adjunct professor at Stanford University. The FDA's drug center is the agency's largest unit, with nearly 6,000 staffers responsible for reviewing the safety and effectiveness of new drugs and monitoring the use and marketing of older drugs. About 2,000 FDA staffers have been laid off as part of widescale cuts to the federal health workforce overseen by Kennedy. More than 1,000 others have taken buyouts or early retirement, while many others are reportedly searching for new jobs. The departures have threatened basic FDA operations, including the timely review of new drugs. FDA's drug center hasn't had a permanent director since January, when Dr. Patrizia Cavazzoni stepped down days before President Donald Trump took office. Nearly all of the FDA's senior leadership positions have turned over in recent months, either due to retirements, resignations or actions by administration officials placing them on administrative leave. FDA center directors typically hold their positions for years or even decades, serving across multiple administrations, whether Republican or Democrat. In May, Makary named Dr. Vinay Prasad, a prominent critic of the FDA's COVID response, to run the agency's vaccine center. He was also named to the post of FDA chief medical officer. Prasad joined the agency after his predecessor, longtime vaccine chief Dr. Peter Marks, was forced out in March. The head of FDA's tobacco center was also forced to step down in April. A permanent replacement has not yet been named. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store